Overview Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012 Status: Completed Trial end date: 2018-08-20 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in healthy male volunteers. Phase: Phase 1 Details Lead Sponsor: Addpharma Inc.